News

The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...
A groundbreaking study by the National Institutes of Health (NIH) is shifting the conversation around hormone therapy and ...
Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...
Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...
Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology.
Menopause causes a range of symptoms. Some supplements may help. Learn which menopause supplements can help ease symptoms.
T heir names are unknown but their pain is nonetheless evident. A user on Reddit, a social-media site, was “fairly close to ...
Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) announced on Thursday that their jointly developed antitumor agent Xtandi reached its secondary goal as part of a combination therapy ...